Target
Prostaglandin E2 receptor EP4 subtype
Ligand
BDBM50205275
Substrate
n/a
Meas. Tech.
ChEMBL_425875 (CHEMBL907936)
Ki
>15200±n/a nM
Citation
 Sturino, CFO'Neill, GLachance, NBoyd, MBerthelette, CLabelle, MLi, LRoy, BScheigetz, JTsou, NAubin, YBateman, KPChauret, NDay, SHLévesque, JFSeto, CSilva, JHTrimble, LACarriere, MCDenis, DGreig, GKargman, SLamontagne, SMathieu, MCSawyer, NSlipetz, DAbraham, WMJones, TMcAuliffe, MPiechuta, HNicoll-Griffith, DAWang, ZZamboni, RYoung, RNMetters, KM Discovery of a potent and selective prostaglandin D2 receptor antagonist, [(3R)-4-(4-chloro-benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic acid (MK-0524). J Med Chem 50:794-806 (2007) [PubMed]  Article 
Target
Name:
Prostaglandin E2 receptor EP4 subtype
Synonyms:
PE2R4_HUMAN | PGE receptor EP4 subtype | PGE2 receptor EP4 subtype | PTGER2 | PTGER4 | Prostaglandin E2 receptor | Prostanoid EP4 receptor
Type:
Enzyme
Mol. Mass.:
53134.53
Organism:
Homo sapiens (Human)
Description:
P35408
Residue:
488
Sequence:
MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI
  
Inhibitor
Name:
BDBM50205275
Synonyms:
CHEMBL426559 | [(3R)-4-(4-chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic acid
Type:
Small organic molecule
Emp. Form.:
C21H19ClFNO4S
Mol. Mass.:
435.896
SMILES:
CS(=O)(=O)c1cc(F)cc2c3CC[C@H](CC(O)=O)c3n(Cc3ccc(Cl)cc3)c12
Structure:
Search PDB for entries with ligand similarity: